The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy ; volume:6 ; number:1 ; day:8 ; month:9 ; year:2023 ; pages:1-21 ; date:12.2023
Communications biology ; 6, Heft 1 (8.9.2023), 1-21, 12.2023
- Creator
-
Ali, Amr
Mekhaeil, Bassem
Biziotis, Olga-Demetra
Tsakiridis, Evangelia E.
Ahmadi, Elham
Wu, Jianhan
Wang, Simon
Singh, Kanwaldeep
Menjolian, Gabe
Farrell, Thomas
Mesci, Aruz
Liu, Stanley
Berg, Tobias
Bramson, Jonathan L.
Steinberg, Gregory R.
Tsakiridis, Theodoros
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-023-05289-w
- URN
-
urn:nbn:de:101:1-2024013111500184784830
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ali, Amr
- Mekhaeil, Bassem
- Biziotis, Olga-Demetra
- Tsakiridis, Evangelia E.
- Ahmadi, Elham
- Wu, Jianhan
- Wang, Simon
- Singh, Kanwaldeep
- Menjolian, Gabe
- Farrell, Thomas
- Mesci, Aruz
- Liu, Stanley
- Berg, Tobias
- Bramson, Jonathan L.
- Steinberg, Gregory R.
- Tsakiridis, Theodoros
- SpringerLink (Online service)
Other Objects (12)
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer